 |  |  |  |  |  |  |
 | Standard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages) |
 |  | FOREWORD |
 |  | ACKNOWLEDGMENTS |
 |  | INTRODUCTION |
 |  | Standard Treatment Guidelines (STG) |
 |  |  | 1. GASTROINTESTINAL CONDITIONS |
 |  |  |  | 1.1 Parasitic Diseases |
 |  |  |  |  | 1.1.1 Amoebiasis |
 |  |  |  |  | 1.1.2 Ascariasis (Round Worms) |
 |  |  |  |  | 1.1.3 Ancylostomiasis (Hookworm Disease) |
 |  |  |  |  | 1.1.4 Cestodiasis (Tapeworms) |
 |  |  |  |  | 1.1.5 Filariasis |
 |  |  |  |  | 1.1.6 Giardiasis |
 |  |  |  |  | 1.1.7 Strongyloidiasis |
 |  |  |  |  | 1.1.8 Typhoid and paratyphoid |
 |  |  |  |  | 1.1.9 Schistosomiasis |
 |  |  |  | 1.2 Bacillary Dysentery |
 |  |  |  | 1.3 Diarrhoea |
 |  |  |  |  | 1.3.1 Management of diarrhoea in children |
 |  |  |  |  | 1.3.2 Special Notes on Management |
 |  |  |  | 1.4 Cholera |
 |  |  |  |  | 1.4.1 Moderate Dehydration |
 |  |  |  |  | 1.4.2 Severe Dehydration |
 |  |  |  | 1.5 Ulcers and related conditions |
 |  |  |  |  | 1.5.1 Peptic Ulcer-General Measures |
 |  |  |  |  | 1.5.2 Oesophageal Ulcer |
 |  |  |  |  | 1.5.3 Gastric Ulcer |
 |  |  |  |  | 1.5.4 Duodenal Ulcer |
 |  |  |  |  | 1.5.5 Non-Ulcer Dyspepsia |
 |  |  |  |  | 1.5.6 Acute Gastritis |
 |  |  |  |  | 1.5.7 Gastro-Enteritis (Food Poisoning Viral) |
 |  |  |  |  | 1.5.8 Ulcerative colitis |
 |  |  |  | 1.6 Other gastro-intestinal problems |
 |  |  |  |  | 1.6.1 Irritable Bowel Syndrome |
 |  |  |  |  | 1.6.2 Malabsorption Syndrome |
 |  |  |  |  | 1.6.3 Tropical Sprue |
 |  |  |  |  | 1.6.4 Pernicious Anaemia |
 |  |  |  |  | 1.6.5 Chronic Pancreatitis |
 |  |  |  |  | 1.6.6 Disaccharides Deficiency |
 |  |  |  |  | 1.6.7 Peritonitis |
 |  |  |  |  | 1.6.8 Constipation |
 |  |  |  |  | 1.6.9 Haemorrhoids and other Peri-Anal Conditions |
 |  |  |  | 1.7 Liver Diseases Conditions |
 |  |  |  |  | 1.7.1 Liver Cirrhosis |
 |  |  |  |  | 1.7.2 Acute Liver Failure/Hepatic Encephalopathy |
 |  |  | 2. RESPIRATORY DISEASES |
 |  |  |  | 2.1 Acute Respiratory Infections (ARI) |
 |  |  |  |  | 2.1.1 Pneumonia |
 |  |  |  |  | 2.1.2 ARI in Children |
 |  |  |  |  | 2.1.3 Wheezing |
 |  |  |  |  | 2.1.4 Croup |
 |  |  |  |  | 2.1.5 Laryngeal Diphtheria |
 |  |  |  |  | 2.1.6 ARI in Adult |
 |  |  |  |  |  | 2.1.6.1 Community Acquired Infections |
 |  |  |  |  |  | 2.1.6.2 Hospital Acquired Infections |
 |  |  |  |  | 2.1.7 Chronic Bronchitis |
 |  |  |  |  | 2.1.8 Other Respiratory Infections |
 |  |  |  |  | 2.1.9 Asthma |
 |  |  |  |  |  | 2.1.9.1 Chronic Asthma in Adults |
 |  |  |  |  |  | 2.1.9.2 Moderate Asthma in Adults |
 |  |  |  |  |  | 2.1.9.3 Severe Asthma in Adults |
 |  |  |  |  |  | 2.1.9.4 Maintenance therapy in children |
 |  |  |  |  | 2.1.10 Cough |
 |  |  |  |  | 2.1.11 Whooping Cough |
 |  |  |  |  | 2.1.12 Allergic rhinitis |
 |  |  | 3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION |
 |  |  |  | 3.1 Infection of the Genital Urinary Tact |
 |  |  |  |  | 3.1.1 Urinary Tract Infection During Pregnancy |
 |  |  |  |  | 3.1.2 Positive RPR or Syphilis during pregnancy |
 |  |  |  |  | 3.1.3 Vaginal Discharge During Pregnancy |
 |  |  |  | 3.2 Abortion |
 |  |  |  | 3.3 Prolonged Rupture Of Membrane (PROM) |
 |  |  |  | 3.4 Prophylaxis for Caesarian Section |
 |  |  |  | 3.5 Nausea and Vomiting in Pregnancy |
 |  |  |  | 3.6 Anaemia During Pregnancy |
 |  |  |  | 3.7 Hypertension in Pregnancy |
 |  |  |  |  | 3.7.1 Essential Hypertension |
 |  |  |  |  | 3.7.2 Pregnancy Induced hypertension (PIH) |
 |  |  |  |  | 3.7.3 Mild PIH |
 |  |  |  |  | 3.7.4 Moderate PIH |
 |  |  |  |  | 3.7.5 Severe PIH |
 |  |  |  |  | 3.7.6 Pre-Eclamptic Toxaemia (Proteinuria PIH) |
 |  |  |  |  | 3.7.7 Imminent Eclampsia |
 |  |  |  |  | 3.7.8 Eclampsia (Proteinuria PIH with Fits) |
 |  |  |  | 3.8 Diabetes in Pregnancy |
 |  |  |  | 3.9 Anaesthesia, Analgesia, Antacids |
 |  |  |  | 3.10 Steroids in Respiratory Distress Syndrome |
 |  |  |  | 3.11 Myometrial Stimulants (Oxytocics) |
 |  |  |  | 3.12 Uterine Stimulation After Delivery |
 |  |  |  | 3.13 Myometrial Relaxants (Stimulants) |
 |  |  |  | 3.14 Termination of Pregnancy |
 |  |  |  | 3.15 Drugs in Pregnancy and Lactation |
 |  |  |  | 3.16 Pelvic Inflammatory Diseases |
 |  |  |  | 3.17 Hormonal Contraceptives |
 |  |  |  |  | 3.17.1 Check List Questions |
 |  |  |  |  | 3.17.2 Oral Contraceptives |
 |  |  |  |  | 3.17.3 Drugs Reducing Effect of Oral Contraceptives |
 |  |  |  |  | 3.17.4 Drugs made less Effective by Oral Contraceptives |
 |  |  |  |  | 3.17.5 Post Coital Contraception (“morning-after pill”) |
 |  |  |  |  | 3.17.6 Long Term Hormonal Contraceptives |
 |  |  |  |  | 3.17.7 Implant Contraceptive |
 |  |  |  | 3.18 Antepartum Haemorrhage (APH) |
 |  |  |  | 3.19 Dysmenorrhoea |
 |  |  |  | 3.20 Infertility |
 |  |  | 4. CARDIOVASCULAR DISEASES |
 |  |  |  | 4.1 Infections |
 |  |  |  |  | 4.1.1 Prophylaxis of Bacterial Endocarditis |
 |  |  |  |  | 4.1.2 Dental and upper Respiratory Tract Procedure |
 |  |  |  |  | 4.1.3 Parenteral Regimen Required for Genital-Urinary Procedures |
 |  |  |  |  | 4.1.4 Patient with Prosthetic Valve |
 |  |  |  | 4.2 Rheumatic Heart Disease |
 |  |  |  |  | 4.2.1 Rheumatic Fever |
 |  |  |  |  | 4.2.2 Antibiotics Prophylaxis after Rheumatic Fever |
 |  |  |  | 4.3 Treatment of Acute Arthritis and Carditis |
 |  |  |  | 4.4 Hypertension |
 |  |  |  |  | 4.4.1 Mild Hypertension |
 |  |  |  |  | 4.4.2 Moderate/Severe Hypertension |
 |  |  |  | 4.5 Cardiac failure |
 |  |  |  |  | 4.5.1 Mild to Moderate and Severe Cardiac Failure |
 |  |  |  |  | 4.5.2 Acute Pulmonary Oedema |
 |  |  |  |  | 4.5.3 Resistant cardiac failure |
 |  |  |  | 4.6 Angina Pectoris |
 |  |  |  |  | 4.6.1 Stable Angina/Infrequent Attacks |
 |  |  |  |  | 4.6.2 Frequent Attacks |
 |  |  |  | 4.7 Myocardial Infarction (Ml) |
 |  |  |  |  | 4.7.1 General Measures |
 |  |  |  |  | 4.7.2 Left Ventricular (Pump) Failure |
 |  |  |  |  | 4.7.3 Arrhythmias |
 |  |  |  |  | 4.7.4 Tachycardia |
 |  |  |  |  | 4.7.5 Rehabilitation |
 |  |  |  |  | 4.7.6 Prevention of Re-infarction |
 |  |  | 5. MALARIA |
 |  |  |  | 5.1 General Guidelines |
 |  |  |  | 5.2 Uncomplicated Malaria, Chloroquine Sensitive |
 |  |  |  | 5.3 Uncomplicated Malaria, Chloroquine resistant |
 |  |  |  | 5.4 Malaria due to vivax/ovale |
 |  |  |  | 5.5 Complicated Malaria |
 |  |  |  |  | 5.5.1 General measure |
 |  |  | 6. SKIN DISEASES |
 |  |  |  | 6.1 Bacterial Phyzogenic Skin Infections |
 |  |  |  |  | 6.1.1 Impetigo |
 |  |  |  |  | 6.1.2 Folliculitis |
 |  |  |  |  | 6.1.3 Furunculosis |
 |  |  |  |  | 6.1.4 Erysipelas |
 |  |  |  |  | 6.1.5 Acute Cellulitis |
 |  |  |  |  | 6.1.6 Acne |
 |  |  |  |  | 6.1.7 Paranychia |
 |  |  |  | 6.2 SKIN FUNGAL INFECTIONS |
 |  |  |  |  | 6.2.1 Dermatophytosis (Ringworm) |
 |  |  |  |  | 6.2.2 Tinea Corporis (Body Ringworm) |
 |  |  |  |  | 6.2.3 Tinea Capitis (Scalp Ringworm) |
 |  |  |  |  | 6.2.4 Tinea Versicolor (Pityrias Versicolor) |
 |  |  |  |  | 6.2.5 Tinea Pedis (Athlete's Foot) |
 |  |  |  | 6.3 OTHER FUNGAL DISEASES |
 |  |  |  |  | 6.3.1 Candidiasis |
 |  |  |  |  | 6.3.2 Deep Fungal Infections |
 |  |  |  | 6.4 Scabies |
 |  |  |  | 6.5 Herpes Simplex |
 |  |  |  | 6.6 Herpes Zoster (Shingles) |
 |  |  |  | 6.7 Chicken Pox |
 |  |  |  | 6.8 OTHER SKIN DISEASES |
 |  |  |  |  | 6.8.1 Allergic Contact Dermatitis |
 |  |  |  |  | 6.8.2 Eczema |
 |  |  |  |  | 6.8.3 Urticaria |
 |  |  |  |  | 6.8.4 Psoriasis |
 |  |  |  |  | 6.8.5 Pellagra |
 |  |  |  |  | 6.8.6 Depigmented Skin |
 |  |  |  |  | 6.8.7 Brucellosis (Undulant Fever) |
 |  |  |  |  | 6.8.8 Lichen Planus |
 |  |  | 7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD) |
 |  |  |  | 7.1 General Guidelines |
 |  |  |  | 7.2 Reasoning Behind STD Drug Treatment Regimens |
 |  |  |  | 7.3 Gonorrhoea |
 |  |  |  | 7.4 Chancroid |
 |  |  |  | 7.5 Epididymo-Orchitis |
 |  |  |  | 7.6 Chlamydia Infections |
 |  |  |  | 7.7 Syphilis |
 |  |  |  | 7.8 Genital Warts |
 |  |  |  | 7.9 Trichomoniasis |
 |  |  |  | 7.10 The Syndrome Treatment of STD |
 |  |  |  |  | 7.10.1 In Men |
 |  |  |  |  | 7.10.2 In Women |
 |  |  | 8. DENTAL AND ORAL CONDITIONS |
 |  |  |  | 8.1 Dental Infections |
 |  |  |  |  | 8.1.1 Periapical Abscess |
 |  |  |  |  | 8.1.2 Infected (Dry) Socket |
 |  |  |  |  | 8.1.3 Periodontal Conditions |
 |  |  |  |  | 8.1.4 Oral/Mucosal Ulcerations |
 |  |  |  |  | 8.1.5 Infections of the Oral cavity |
 |  |  |  |  | 8.1.6 Pericoronitis |
 |  |  |  |  | 8.1.7 Ludwig's Angina |
 |  |  |  |  | 8.1.8 Dental Abscess |
 |  |  |  | 8.2 Post Extraction Bleeding |
 |  |  |  | 8.3 Tooth Sensitivities |
 |  |  |  | 8.4 Dental Caries |
 |  |  |  | 8.5 Aphthous Ulcerations |
 |  |  |  |  | 8.5.1 Minor aphthous ulcers |
 |  |  |  |  | 8.5.2 Major aphthous ulcers |
 |  |  |  | 8.6 Edentulousness |
 |  |  |  | 8.7 Malocclusions |
 |  |  |  | 8.8 Traumatic Injuries to Teeth in Children |
 |  |  |  | 8.9 Tumours of the Oral Cavity |
 |  |  |  |  | 8.9.1 Benign Odontogenic Tumours |
 |  |  |  |  | 8.9.2 Malignant Odontogenic Tumours |
 |  |  |  |  | 8.9.3 Soft Tissue and Bone Tumours (Non-Odontogenic) |
 |  |  |  |  | 8.9.4 Lymphomas |
 |  |  |  | 8.10 Shedding of Primary (Milk) Teeth |
 |  |  |  | 8.11 Eruption of Teeth |
 |  |  | 9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS |
 |  |  |  | 9.1 Glomerulonephritis |
 |  |  |  | 9.2 Pyelonephritis |
 |  |  |  | 9.3 Nephrotic Syndrome |
 |  |  | 10. EAR, NOSE AND THROAT CONDITIONS |
 |  |  |  | 10.1 Otitis (External and Media) |
 |  |  |  |  | 10.1.1 Otitis External |
 |  |  |  |  | 10.1.2 Otitis Media |
 |  |  |  | 10.2 Acute Rhinitis and Sinusitis |
 |  |  |  | 10.3 Pharyngotonsillitis |
 |  |  |  | 10.4 Laryngitis |
 |  |  |  | 10.5 Acute Epiglotitis (AE) |
 |  |  | 11. EYE CONDITIONS |
 |  |  |  | 11.1 Prevention/Management |
 |  |  |  | 11.2 Red Eye |
 |  |  |  | 11.3 Corneal Abrasion |
 |  |  |  | 11.4 Penetrating Injury |
 |  |  |  | 11.5 Chemical Burns |
 |  |  |  | 11.6 Conjunctivitis |
 |  |  |  |  | 11.6.1 Conjunctivitis of the Newborn |
 |  |  |  | 11.7 Unilateral |
 |  |  |  | 11.8 Trachoma |
 |  |  |  | 11.9 Xerophthalmia/Vitamin A Deficiency |
 |  |  | 12. TUBERCULOSIS AND LEPROSY |
 |  |  |  | 12.1 Tuberculosis |
 |  |  |  |  | 12.1.1 Control of Tuberculosis |
 |  |  |  |  | 12.1.2 Case Management |
 |  |  |  |  | 12.1.3 Treatment Categories |
 |  |  |  |  |  | 12.1.3.1 Treatment Guidelines Catagory I |
 |  |  |  |  |  | 12.1.3.2 Treatment guidelines Category II |
 |  |  |  |  | 12.1.4 New Cases Other Than Smear Positive (PT) |
 |  |  |  |  | 12.1.5 Chronic Cases |
 |  |  |  | 12.2 Leprosy |
 |  |  |  |  | 12.2.1 General Information about Leprosy |
 |  |  |  |  |  | 12.2.1.1 When Leprosy Should be Suspected |
 |  |  |  |  |  | 12.2.1.2 Diagnosis of Leprosy |
 |  |  |  |  | 12.2.2 Classification of Leprosy |
 |  |  |  |  |  | 12.2.2.1 Tuberculoid Leprosy |
 |  |  |  |  |  | 12.2.2.2 Borderline Leprosy |
 |  |  |  |  |  | 12.2.2.3 Borderline Tuberculoid (BT) Leprosy |
 |  |  |  |  |  | 12.2.2.4 Borderline Lepromatous (BL) Leprosy |
 |  |  |  |  |  | 12.2.2.5 Lepromatous (LL) leprosy |
 |  |  |  | 12.3 Treatment of Leprosy |
 |  |  |  |  | 12.3.1 Categories of Patients |
 |  |  |  |  | 12.3.2 Where the Patient should be Treated |
 |  |  |  |  | 12.3.3 Duration of Treatment |
 |  |  |  |  | 12.3.4 Procedures During and After Treatment |
 |  |  |  |  | 12.3.5 Responsibilities During Treatment |
 |  |  |  | 12.4 Prevention of Disabilities and rehabilitation |
 |  |  |  | 12.5 Signs and Treatment of Severe Reversal Reaction (RR) |
 |  |  |  |  | 12.5.1 Signs and Treatment of severe Erythema Nodosum Leprosum (ENL) Reaction |
 |  |  |  |  | 12.5.2 Treatment of Mild reaction |
 |  |  |  |  | 12.5.3 Precautions with Prednisolone |
 |  |  |  | 12.6 Responsibilities |
 |  |  |  | 12.7 How to Look After Ulcers |
 |  |  |  | 12.8 Surveillance of Patients After Release from MDT |
 |  |  |  | 12.9 Referral Criteria of Leprosy Patients |
 |  |  | 13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES |
 |  |  |  | 13.1 Infections |
 |  |  |  |  | 13.1.1 Osteomyelitis |
 |  |  |  |  | 13.1.2 Tropical Pyomyositis |
 |  |  |  | 13.2 Inflammatory Conditions |
 |  |  |  |  | 13.2.1 General Guidelines |
 |  |  |  |  | 13.2.2 Rheumatoid Arthritis |
 |  |  |  |  | 13.2.3 Gout |
 |  |  |  |  | 13.2.4 Osteoarthritis |
 |  |  | 14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS |
 |  |  |  | 14.1 Diabetes Mellitus |
 |  |  |  | 14.2 Thyroid Diseases |
 |  |  |  |  | 14.2.1 Hyperthyroidism |
 |  |  |  |  | 14.2.2 Hypothyroidism |
 |  |  | 15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS |
 |  |  |  | 15.1 Infections |
 |  |  |  |  | 15.1.1 Meningitis |
 |  |  |  |  | 15.1.2 Other CNS Infections |
 |  |  |  |  | 15.1.3 Tetanus |
 |  |  |  |  | 15.1.4 Rabies |
 |  |  |  | 15.2 Vascular Headaches |
 |  |  |  | 15.3 Anxiety Neurosis |
 |  |  |  | 15.4 Depressive Psychosis |
 |  |  |  | 15.5 Epilepsies |
 |  |  |  |  | 15.5.1 Status Epilepticus |
 |  |  |  |  | 15.5.2 Serial Epilepsy |
 |  |  |  | 15.6 Schizophrenia |
 |  |  |  | 15.7 Alcohol Dependence Syndrome |
 |  |  |  | 15.8 Substance Abuse |
 |  |  | 16. OTHER DISEASE CONDITIONS |
 |  |  |  | 16.1 Leishmaniasis |
 |  |  |  | 16.2 Trypanosomiasis |
 |  |  |  | 16.3 Anthrax |
 |  |  |  | 16.4 Mastitis (Breast Abscess) |
 |  |  | 17. VIRAL INFECTIONS |
 |  |  |  | 17.1 Measles |
 |  |  |  | 17.2 Poliomyelitis |
 |  |  |  | 17.3 Viral Hepatitis |
 |  |  |  | 17.4 HIV |
 |  |  | 18. ALLERGIC REACTIONS |
 |  |  |  | 18.1 Anaphylaxis (Acute Hypersensitivity) |
 |  |  | 19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS |
 |  |  |  | HAEMATOLOGICAL DISEASE CONDITIONS |
 |  |  |  |  | 19.1 Anaemia |
 |  |  |  |  | 19.2 Sickle Cell Anaemia |
 |  |  |  |  | 19.3 Q6PD deficiency |
 |  |  |  |  | 19.4 Bleeding Disorders |
 |  |  |  |  |  | 19.4.1 Hereditary Bleeding Disorders |
 |  |  |  |  |  | 19.4.2 Haemophilia A (Factor VIII deficiency) |
 |  |  |  |  |  | 19.4.3 Haemophilia B (Factor IX deficiency) |
 |  |  |  |  | 19.5 Von Willebrand Disease (VWD) |
 |  |  |  |  | 19.6 Acquired Bleeding Disorders/Platelet Disorders |
 |  |  |  |  | 19.7 Haemorrhagic Disease of the Newborn |
 |  |  |  |  | 19.8 Anticoagulation |
 |  |  |  | NUTRITIONAL DISEASE CONDITIONS |
 |  |  |  |  | 19.1 Avitaminosis |
 |  |  |  |  |  | 19.1.1 Vitamin A Deficiency |
 |  |  |  |  |  | 19.1.2 Vitamin D Deficiency |
 |  |  |  |  |  | 19.3 Nicotinic Acid Deficiency (Pellagra) |
 |  |  |  |  |  | 19.1.4 Thiamine Deficiency (Beriberi) |
 |  |  |  |  |  | 19.1.5 Riboflavin Deficiency |
 |  |  |  |  |  | 19.1.6 Pyridoxine Deficiency |
 |  |  |  |  |  | 19.1.7 Ascorbic Acid Deficiency |
 |  |  |  |  |  | 19.1.8 Vitamin K Deficiency |
 |  |  | 20. MALIGNANT DISEASE CONDITIONS |
 |  |  |  | 20.1 Hepatoma |
 |  |  |  | 20.2 Cancer of the Cervix |
 |  |  |  | 20.3 Cancer of the Breast |
 |  |  |  | 20.4 Kaposi's Sarcoma |
 |  |  |  | 20.5 Leukemia |
 |  |  |  | 20.6 Burkitt's Tumour |
 |  |  | 21. INJURIES AND TRAUMA |
 |  |  |  | BITES |
 |  |  |  |  | 21.1 Animal Bites |
 |  |  |  |  | 21.2 Insect Bites |
 |  |  |  |  | 21.3 Snake Bites |
 |  |  |  | BURNS |
 |  |  | 22. FOREIGN BODIES |
 |  |  | 23. PAIN |
 |  |  | 24. POISONING |
 |  |  | 25. NORMAL LABORATORY VALUES |
 |  | NATIONAL ESSENTIAL DRUG LIST |
 |  |  | 1. ANAESTHETICS |
 |  |  | 2. MUSCLE RELAXANTS AND CHOLINESTERASE INHIBITORS |
 |  |  | 3. ANALGESICS, ANTIPYRETICS |
 |  |  | 4. ANTIMIGRAINE DRUGS |
 |  |  | 5. ANTI-ALLERGICS AND DRUGS USED IN ANAPHYLAXIS AND SHOCK |
 |  |  | 6. ANTIDOTES |
 |  |  | 7. ANTIEPILEPTICS AND ANTICONVULSANTS |
 |  |  | 8. ANTI-INFECTIVE DRUGS |
 |  |  | 9. ANTINEOPLASTIC DRUGS AND IMMUNOSUPPRESSIVE DRUGS |
 |  |  | 10. ANTI-PARKINSONISM DRUGS |
 |  |  | 11. DRUGS AFFECTING THE BLOOD |
 |  |  | 12. PLASMA SUBSTITUTES, BLOOD PRODUCTS |
 |  |  | 13. CARDIOVASCULAR DRUGS |
 |  |  | 14. DERMATOLOGICAL DRUGS |
 |  |  | 15. DIURETICS |
 |  |  | 16. GASTROINTESTINAL DRUGS |
 |  |  | 17. HORMONES, ANTIDIABETIC AGENTS, ENDOCRINE DRUGS, CONTRACEPTIVES |
 |  |  | 18. DIAGNOSTIC AGENTS |
 |  |  | 19. IMMUNOLOGICALS |
 |  |  | 20. OPHTHALMOLOGICAL PREPARATIONS |
 |  |  | 21. DRUGS USED IN EAR, NOSE AND THROAT (ENT) |
 |  |  | 22. OXYTOCICS & ANTI-OXYTOCICS |
 |  |  | 23. PSYCHOTHERAPEUTIC DRUGS |
 |  |  | 24. RESPIRATORY TRACT DRUGS |
 |  |  | 25. SOLUTION, CORRECTING WATER ELECTROLYTE AND ACID BASE DISTURBANCES |
 |  |  | 26. DISINFECTANTS and ANTISEPTICS |
 |  |  | 27. VITAMINS & MINERALS |
 |  |  | 28. DENTAL DRUGS/SUPPLIES |
 |  |  | 29. VILLAGE HEALTH POSTS |
 |  |  | 30. ESSENTIAL LABORATORY DIAGNOSTIC REAGENT |
 |  | ABBREVIATIONS AND SYMBOLS |